This Biotech Company Announces Groundbreaking Research For Crohn's Disease Treatment

Organovo's FXR314 3D Human Tissue Model: A Significant Leap in Treating Crohn’s and Colitis.

Disclaimer: This post includes affiliate links. If you purchase anything through these affiliated links, the author/website may earn a commission.

Organovo, a leading biotechnology company, recently announced groundbreaking findings from their research on the FXR314 3D human tissue model. The results, presented at the Crohn's and Colitis Congress, indica…